IP Library Granted Patent US 6,906,182
Granted Patent B2
US 6,906,182 · App. 09/998,497 · Granted Jun 14, 2005

Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and method of use

Assignees: Cell Works Therapeutics, Inc.; Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,906,182
App. No.
09/998,497
Granted
Jun 14, 2005
Kind
B2
Abstract

A conjugate of formula A-L-P, in which: A represents a glycosylated/galactosylated peptide that binds to a cell-surface receptor, L represents a bifunctional linker, which does not comprise a naturally occurring amino acid and is covalently bonded to A and P in a regiospecific manner, and P represents a monomer, homopolymer or heteropolymer comprising at least one nucleotide or an analogue thereof, which inhibits the intracellular biosynthesis of nucleotides or nucleic acids in a sequence-independent manner, wherein either or both of the covalent bond between A and L and the covalent bond between L and P can be cleaved intracellularly; a composition comprising such a conjugate; and a method of inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal.

Claims (3)

1. A compound having the formula

2. A method of treating hepatocellular carcinoma comprising administering to a patient in need thereof a composition compnsing the compound of claim 1 .

3. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

Assignments (8)
CONFIRMATORY LICENSE Recorded Nov 8, 2022
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061689/0308 →
CHANGE OF NAME Recorded Sep 30, 2008
From: CELLPOINT DIAGNOSTICS, INC.
To: CELLECTIVE DX CORPORATION
Reel/Frame 021612/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2007
From: CELL WORKS THERAPEUTICS, INC.
To: CELLPOINT DIAGNOSTICS, INC.
Reel/Frame 019980/0871 →
RELEASE OF SECURITY INTEREST Recorded Aug 8, 2007
From: TIGER TECHNOLOGY LIMITED
To: CELL WORKS THERAPEUTICS INC.
Reel/Frame 019666/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2006
From: JOHNS HOPKINS UNIVERSITY
To: CELL WORKS THERAPEUTICS, INC.
Reel/Frame 018260/0379 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2005
From: TS'O, PAUL O.P.; DUFF, ROBERT; DEAMOND, SCOTT
To: CELL WORKS THERAPEUTICS, INC.; JOHNS HOPKINS UNIVERSITY
Reel/Frame 015540/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2004
From: TS'O, PAUL O.P.; DUFF, ROBERT; DEAMOND, SCOTT
To: CELL WORKS THERAPEUTICS, INC.; JOHNS HOPKINS UNIVERSITY
Reel/Frame 015897/0773 →
SECURITY INTEREST Recorded Nov 12, 2003
From: CELL WORKS THERAPEUTICS INC.
To: TIGER TECHNOLOGY LTD.
Reel/Frame 014669/0216 →
Continuity (2)
Provisional Application 6025013900 · Dec 1, 2000
Related Publication 20030032584A1 · Feb 13, 2003